HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuzhen Guo Selected Research

Collagen

7/2020Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
1/2019Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice.
12/2017Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuzhen Guo Research Topics

Disease

16Stroke (Strokes)
11/2021 - 05/2008
6Heart Failure
01/2022 - 12/2013
5Traumatic Brain Injuries (Traumatic Brain Injury)
01/2019 - 11/2009
5Ischemia
12/2018 - 01/2011
4Brain Ischemia (Cerebral Ischemia)
11/2021 - 11/2009
4Inflammation (Inflammations)
12/2020 - 08/2010
4Fibrosis (Cirrhosis)
12/2020 - 01/2019
4Insulin Resistance
12/2020 - 09/2012
4Cardiovascular Diseases (Cardiovascular Disease)
07/2020 - 01/2012
4Infarction (Infarctions)
01/2020 - 11/2009
4Myocardial Ischemia (Ischemic Heart Diseases)
12/2016 - 01/2013
3Cardiomegaly (Heart Hypertrophy)
02/2022 - 01/2019
3Ischemic Stroke
11/2021 - 12/2015
3Brain Injuries (Brain Injury)
11/2021 - 11/2009
3Hyperglycemia
01/2020 - 08/2013
3Type 2 Diabetes Mellitus (MODY)
01/2020 - 01/2013
3Wounds and Injuries (Trauma)
01/2016 - 11/2009
3Hypoxia (Hypoxemia)
11/2012 - 05/2008
2Hypertrophy
02/2022 - 12/2020
2COVID-19
01/2021 - 01/2020
2Body Weight (Weight, Body)
10/2020 - 01/2013
2Ventricular Remodeling
07/2020 - 07/2018
2Neoplasms (Cancer)
01/2020 - 01/2019
2Edema (Dropsy)
01/2019 - 01/2011
2Brain Infarction
12/2018 - 12/2017
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2018 - 01/2011
2Embolic Stroke
12/2017 - 02/2014
2Coronary Disease (Coronary Heart Disease)
01/2016 - 01/2012
2Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
02/2015 - 12/2013
1Mental Fatigue
01/2022
1Hemorrhage
01/2021
1Cough
01/2021
1Endotoxemia
10/2020
1Obesity
10/2020
1Vascular Remodeling
06/2020
1Asthma (Bronchial Asthma)
01/2020
1Cicatrix (Scar)
01/2020
1Fever (Fevers)
01/2020
1Hyperoxia
01/2020
1Hypertrophic Cicatrix (Hypertrophic Scar)
01/2020
1Central Nervous System Diseases (CNS Diseases)
11/2019

Drug/Important Bio-Agent (IBA)

8Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2012
7Glucose (Dextrose)FDA LinkGeneric
06/2020 - 05/2008
5Matrix Metalloproteinases (MMPs)IBA
07/2020 - 11/2009
5Messenger RNA (mRNA)IBA
01/2020 - 09/2012
4Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2017
3Blood Glucose (Blood Sugar)IBA
01/2021 - 09/2012
3Pharmaceutical PreparationsIBA
10/2020 - 01/2012
3si-miao-yong-an decoctionIBA
07/2020 - 01/2019
3CollagenIBA
07/2020 - 12/2017
3LDL Lipoproteins (beta Lipoproteins)IBA
01/2020 - 12/2013
3Neuroprotective AgentsIBA
01/2020 - 07/2011
2AcidsIBA
02/2022 - 06/2020
2LigandsIBA
11/2021 - 12/2016
2CholesterolIBA
01/2021 - 01/2013
2LipidsIBA
12/2020 - 02/2015
2fibroblast growth factor 21IBA
01/2020 - 12/2018
2N-Methylaspartate (NMDA)IBA
01/2020 - 05/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 02/2014
2Immunoglobulin G (IgG)IBA
01/2019 - 12/2017
2Atrial Natriuretic Factor (ANF)IBA
01/2019 - 01/2019
2salicylhydroxamic acid (SHAM)IBA
01/2019 - 01/2016
2Therapeutic UsesIBA
07/2018 - 01/2011
2cadherin 5IBA
12/2017 - 09/2012
2Tissue Plasminogen Activator (Alteplase)FDA Link
12/2017 - 02/2014
2Annexin A2 (Annexin II)IBA
12/2017 - 02/2014
2oxidized low density lipoproteinIBA
02/2015 - 12/2013
2danqi tongmaiIBA
02/2015 - 02/2014
2Triglycerides (Triacylglycerol)IBA
02/2015 - 01/2013
2GlucansIBA
01/2013 - 06/2012
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2013 - 06/2012
2Oxygen (Dioxygen)IBA
11/2012 - 05/2008
2Conditioned Culture MediaIBA
11/2012 - 05/2008
2EnzymesIBA
01/2011 - 09/2007
2ImmunosorbentsIBA
01/2011 - 09/2007
1Isoproterenol (Isoprenaline)FDA LinkGeneric
02/2022
1caffeic acidIBA
02/2022
1BaZiBuShenIBA
01/2022
1ProteomeIBA
01/2022
1ChemokinesIBA
11/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1ElectrolytesIBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2021
1Alanine Transaminase (SGPT)IBA
01/2021
1salvianolic acid BIBA
10/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020
1InterleukinsIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1tetramethylpyrazineIBA
01/2020
1fibrin fragment D (D-dimer)IBA
01/2020
1SugarsIBA
01/2020
1Thymidine Monophosphate (TMP)IBA
01/2020
1GlycosaminoglycansIBA
01/2020
1Heparitin Sulfate (Heparan Sulfate)IBA
01/2020
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2020
1Free Radical ScavengersIBA
01/2020
1Angiotensin IIIBA
11/2019

Therapy/Procedure

7Therapeutics
12/2018 - 09/2007
2Ligation
02/2015 - 01/2012
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020